Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 17.9B | 27.8B | 23.3B | 22.5B |
| Cost of revenue | 7.9B | 13.2B | 10.4B | 9.9B |
| Gross profit | 10.0B | 14.6B | 12.9B | 12.6B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 7.4B | 12.3B | 9.1B | 8.5B |
| Other operating expenses | — | — | — | — |
| Operating income | 2.6B | 2.3B | 3.9B | 4.0B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 264M | 264M | 219M | 234M |
| Other income expense | 23M | -210M | 41M | 56M |
| Pretax income | 2.3B | 1.8B | 3.7B | 3.9B |
| Tax provision | 499M | 275M | 749M | 776M |
| Net income | 1.8B | 1.5B | 2.9B | 3.1B |
| Basic EPS | 1.3 | 1.1 | 2.1 | 2.2 |
| Diluted EPS | 1.3 | 1.1 | 2.1 | 2.2 |
| Basic average shares | 1.5B | 1.5B | 1.5B | 1.5B |
| Diluted average shares | 1.5B | 1.5B | 1.5B | 1.5B |
| EBITDA | 3.4B | 3.3B | 4.8B | 5.0B |
| Net income from continuing op. | 1.8B | 1.5B | 2.9B | 3.1B |
| Minority interests | -9M | -11M | -15M | -11M |
| Preferred stock dividends | — | — | — | — |